With New FDA Approval, The Migraine Medication Revolution Continues
The FDA’s approval of Ubrelvy is the next step in a bigger trend of new migraine medications.
Related Articles
2024 Medical Cannabis Consumer Experience Survey
Your voice matters! Take our survey and share your experiences as a medical cannabis consumer. Your responses will help inform policy and further research.
U.S. Pain Foundation – serving patients with chronic pain
U.S. Pain Foundation is a 501 (c)3 non-profit organization dedicated to serving those who live with pain conditions and their care providers. We are here…
New – National support groups for chronic pain – Pain Connection %
Pain Connection offers support groups for people living with chronic pain. Meetings are held weekly over videoconference.
U.S. Pain Foundation – serving patients with chronic pain
U.S. Pain Foundation is a 501 (c)3 non-profit organization dedicated to serving those who live with pain conditions and their care providers. We are here…
Reflecting on 2024: Progress for Those with Pain
Email from U.S. Pain Foundation Dear U.S. Pain Foundation community, As 2024 draws to a close, we reflect on a year of significant progress and…
Watch: A conversation on today’s treatment landscape and the current state of pain
On Tuesday, Dec. 10 at 9:30am ET, Axios will host an event in Miami looking at the challenges in today’s treatment landscape and the current…
Constipation and chronic pain
Short on time? Check out this ‘Health hack’ for quick tips and resources to help improve your health. Tune in to hear directly from our…
Exploring the DPN Pipeline: Insights, Innovations, and Hope – U.S. Pain Foundation
Get the facts on diabetic peripheral neuropathy (DPN): who’s at risk, symptoms, and key management tips to prevent serious complications.